COM:KRONOSBIO
Kronos Bio, Inc.
- Stock
Last Close
0.87
22/11 21:00
Market Cap
75.72M
Beta: -
Volume Today
96.67K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -6.72M - | -16.12M 139.80% | -88.44M 448.76% | -151.08M 70.82% | -133.20M 11.83% | -112.67M 15.41% | |
depreciation and amortization | 91K - | 356K 291.21% | 839K 135.67% | 1.98M 135.64% | 2.27M 14.62% | 2.14M 5.74% | |
deferred income tax | -4K - | 326K 8,250% | 4.00M 1,126.07% | ||||
stock based compensation | 30K - | 113K 276.67% | 3.75M 3,221.24% | 26.21M 598.40% | 31.14M 18.82% | 24.98M 19.79% | |
change in working capital | 90K - | 276K 206.67% | 6.46M 2,240.58% | -1.62M 125.08% | 6.18M 481.36% | -4.15M 167.14% | |
accounts receivables | |||||||
inventory | |||||||
accounts payables | -28K - | 716K 2,657.14% | 2.81M 292.04% | -3.19M 213.82% | 4.03M 225.98% | -4.15M 203.06% | |
other working capital | 118K - | -440K 472.88% | 3.65M 930.23% | 1.57M 56.88% | 2.15M 36.70% | 4.15M 92.66% | |
other non cash items | 69K - | 294K 326.09% | 39.15M 13,217.69% | 2.59M 93.39% | 2.69M 3.86% | 6.97M 159.32% | |
net cash provided by operating activities | -6.44M - | -15.08M 134.16% | -37.91M 151.37% | -117.92M 211.05% | -90.93M 22.89% | -78.58M 13.58% | |
investments in property plant and equipment | -1.07M - | -2.95M 174.23% | -9.57M 224.56% | -4.26M 55.48% | -577K 86.46% | -679K 17.68% | |
acquisitions net | 150.67M - | -67.98M 145.12% | 31.64M 146.55% | ||||
purchases of investments | -64.63M - | -229.33M 254.82% | -177.73M 22.50% | -367.12M 106.56% | -212.96M 41.99% | ||
sales maturities of investments | 78.66M - | 245.72M 212.38% | 335.48M 36.53% | 280.00M 16.54% | |||
other investing activites | -150.67M - | 67.98M 145.12% | -31.64M 146.55% | ||||
net cash used for investing activites | -1.07M - | -67.58M 6,186.60% | -160.24M 137.10% | 63.72M 139.77% | -32.22M 150.56% | 66.37M 305.97% | |
debt repayment | -72K - | -30K 58.33% | -32K 6.67% | -5K 84.38% | |||
common stock issued | 5K - | 115K 2,200% | 263.73M 229,226.09% | 4.46M 98.31% | 471K 89.45% | ||
common stock repurchased | 1.34M - | 380K 71.60% | 538K 41.58% | ||||
dividends paid | -4.46M - | ||||||
other financing activites | 16.29M - | 104.92M 544.29% | 151.92M 44.79% | 3.13M 97.94% | 29K - | ||
net cash used provided by financing activities | 16.22M - | 105.01M 547.47% | 415.61M 295.80% | 4.46M 98.93% | 851K 80.92% | 567K 33.37% | |
effect of forex changes on cash | |||||||
net change in cash | 8.70M - | 22.34M 156.77% | 217.47M 873.26% | -49.74M 122.87% | -122.30M 145.87% | -11.65M 90.48% | |
cash at beginning of period | 1.52M - | 10.23M 571.00% | 32.57M 218.50% | 250.04M 667.69% | 200.30M 19.89% | 78.00M 61.06% | |
cash at end of period | 10.23M - | 32.57M 218.50% | 250.04M 667.69% | 200.30M 19.89% | 78.00M 61.06% | 66.35M 14.93% | |
operating cash flow | -6.44M - | -15.08M 134.16% | -37.91M 151.37% | -117.92M 211.05% | -90.93M 22.89% | -78.58M 13.58% | |
capital expenditure | -1.07M - | -2.95M 174.23% | -9.57M 224.56% | -4.26M 55.48% | -577K 86.46% | -679K 17.68% | |
free cash flow | -7.52M - | -18.03M 139.89% | -47.48M 163.34% | -122.18M 157.34% | -91.50M 25.11% | -79.26M 13.38% |
All numbers in (except ratios and percentages)